TRIMEDX Adds Agentic AI to TRIMEDX-AIQ for Capital Planning and Inventory Optimization
New agentic functionality is designed to support capital planning decisions and inventory management for health systems.
New agentic functionality is designed to support capital planning decisions and inventory management for health systems.
New platform combines HTM data with AI tools to improve equipment visibility, maintenance planning, and supply chain workflows for health systems.
As AI becomes embedded in medical equipment, HTM professionals must navigate new questions of accuracy, accountability, and risk.
New agentic functionality is designed to support capital planning decisions and inventory management for health systems.
The collaboration will make BC Group’s biomedical test and measurement equipment available through reLink Medical’s marketplace.
The system integrates updated imaging hardware, AI-driven tools, and independently validated ergonomic features aimed at supporting diagnostic accuracy and user comfort.
The FDA 510(k) pending Carestation 850 is designed to help anesthesia teams address growing clinical complexity, workflow demands, and sustainability goals.
With care increasingly delivered across many settings, health systems are reworking how technology is supported and secured.
Rigel Medical has partnered with MEAK Solutions to enhance the supply and support of biomedical test equipment for US government sectors.
A researcher has received $3 million to develop a one-millimeter scope using optical coherence tomography to visualize fallopian tube damage.
The platform’s 510(k) clearance adds PET-CT workflows—including SUV quantification, fusion, MIP, and MPR—to its browser-based diagnostic environment, advancing unified cloud imaging infrastructure.
The device features a cloud-based platform for secure data transfer, streamlined software upgrades, and customizable configurations for clinical workflows.
The system is designed to streamline quality processes and simplify adherence to ISO, FDA, and EU MDR requirements for regulated industries.
The investigational device exemption study will evaluate the safety and effectiveness of the system for hysterectomy procedures.